ID

16663

Beschreibung

Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00292253

Link

https://clinicaltrials.gov/show/NCT00292253

Stichworte

  1. 30.07.16 30.07.16 -
Hochgeladen am

30. Juli 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Multiple Sclerosis, Relapsing-remitting NCT00292253

Eligibility Multiple Sclerosis, Relapsing-remitting NCT00292253

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
greater than or equal to 18 years of age
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
has relapsing-remitting ms
Beschreibung

relapsing-remitting ms

Datentyp

boolean

Alias
UMLS CUI [1]
C0751967
are willing and able to comply with the protocol for the duration of the study
Beschreibung

study compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
has significant leukopenia/lymphopenia (white blood cell count less than (<) 0.5 times the lower limit of normal)
Beschreibung

leukopenia/lymphopenia

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023530
UMLS CUI [1,2]
C0023508
UMLS CUI [2]
C0024312
has elevated liver function tests (aspartate aminotransferase [ast], alanine transaminase [alt], or alkaline phosphatase greater than (>) 2 times the upper limit of normal or total bilirubin > 1.5 times the upper limit of normal)
Beschreibung

has elevated liver function tests

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
UMLS CUI [3]
C1561546
UMLS CUI [4]
C0201913
has an allergy to human serum albumin or mannitol
Beschreibung

has an allergy to human serum albumin or mannitol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0071512
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0024730
had treatment with an investigational product or procedure within 3 months
Beschreibung

had treatment with an investigational product or procedure within 3 months

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0013230
has the presence of systemic disease or abnormal laboratory findings that might interfere with subject safety, compliance or evaluation of the condition under study
Beschreibung

systemic disease interfering with study protocol compliance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
has concomitant use of avonex®, betaseron®, copaxone®, or novantrone®
Beschreibung

concomitant medication

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0594372
UMLS CUI [2,1]
C2347852
UMLS CUI [2,2]
C0284968
UMLS CUI [3,1]
C2347852
UMLS CUI [3,2]
C0282248

Ähnliche Modelle

Eligibility Multiple Sclerosis, Relapsing-remitting NCT00292253

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
greater than or equal to 18 years of age
boolean
C0001779 (UMLS CUI [1])
relapsing-remitting ms
Item
has relapsing-remitting ms
boolean
C0751967 (UMLS CUI [1])
study compliance
Item
are willing and able to comply with the protocol for the duration of the study
boolean
C1321605 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
leukopenia/lymphopenia
Item
has significant leukopenia/lymphopenia (white blood cell count less than (<) 0.5 times the lower limit of normal)
boolean
C0023530 (UMLS CUI [1,1])
C0023508 (UMLS CUI [1,2])
C0024312 (UMLS CUI [2])
has elevated liver function tests
Item
has elevated liver function tests (aspartate aminotransferase [ast], alanine transaminase [alt], or alkaline phosphatase greater than (>) 2 times the upper limit of normal or total bilirubin > 1.5 times the upper limit of normal)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C1561546 (UMLS CUI [3])
C0201913 (UMLS CUI [4])
has an allergy to human serum albumin or mannitol
Item
has an allergy to human serum albumin or mannitol
boolean
C0020517 (UMLS CUI [1,1])
C0071512 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0024730 (UMLS CUI [2,2])
had treatment with an investigational product or procedure within 3 months
Item
had treatment with an investigational product or procedure within 3 months
boolean
C1514463 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
systemic disease interfering with study protocol compliance
Item
has the presence of systemic disease or abnormal laboratory findings that might interfere with subject safety, compliance or evaluation of the condition under study
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
concomitant medication
Item
has concomitant use of avonex®, betaseron®, copaxone®, or novantrone®
boolean
C2347852 (UMLS CUI [1,1])
C0594372 (UMLS CUI [1,2])
C2347852 (UMLS CUI [2,1])
C0284968 (UMLS CUI [2,2])
C2347852 (UMLS CUI [3,1])
C0282248 (UMLS CUI [3,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video